Evaluation of the drug-drug interaction between FosD and verapamil when taken together in healthy volunteers

Study identifier:D4300C00011

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

An Open-label, Single-Centre Study to Assess the Pharmacokinetics of R406 in Healthy Volunteers when Fostamatinib Disodium 150 mg is Administered Alone and in Combination with Verapamil

Medical condition

Drug drug interactions, Healthy Volunteers

Phase

Phase 1

Healthy volunteers

Yes

Study drug

FOSTAMATIN, Verapamil

Sex

All

Actual Enrollment

15

Study type

Interventional

Age

18 Years - 55 Years

Date

Study Start Date: 01 Sept 2010
Primary Completion Date: 01 Oct 2010
Study Completion Date: 01 Oct 2010

Study design

Allocation: Non-randomized
Endpoint Classification: Safety Study
Intervention Model: Crossover Assignment
Masking: Open Label
Primary Purpose: Basic Science

Verification:

Verified 01 Apr 2014 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria